Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
SHISEIDO RADIANT LIFTING FOUNDATION
- Manufacturer
- SHISEIDO AMERICA INC.
- Effective date
- 2019-12-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:49:31
Label at a glance#
ProductSHISEIDO RADIANT LIFTING FOUNDATION I00
Active ingredientOCTINOXATE, TITANIUM DIOXIDE
Label structure26 sections
Dosage and administration
For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the su...
Storage and handling
protect this product in this container from excessive heat and direct sun.
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| ACTIVE INGREDIENTS: | Purpose |
|---|---|
| OCTINOXATE 1.9% | Sunscreen |
| TITANIUM DIOXIDE 4.1% | Sunscreen |
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
- children under 6 months: Ask a doctor
Inactive Ingredients
WATER, GLYCERIN, DIMETHICONE, BUTYLENE GLYCOL, NYLON-12, DIETHYLHEXYL SUCCINATE, DIPHENYLSILOXY PHENYL TRIMETHICONE, LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE, PEG-10 DIMETHICONE, BIS-BUTYLDIMETHICONE POLYGLYCERYL-3, POLYMETHYL METHACRYLATE, TOCOPHERYL ACETATE, LAVANDULA ANGUSTIFOLIA (LAVENDER) OIL, HYDROXYPROLINE, PEG/PPG-36/41 DIMETHYL ETHER, CYCLOMETHICONE, DISTEARDIMONIUM HECTORITE, ALUMINUM HYDROXIDE, ALUMINUM DISTEARATE, ALUMINA, TRISODIUM EDTA, TRIETHOXYCAPRYLYLSILANE, POLYSILICONE-2, TOCOPHEROL, SODIUM METABISULFITE, HYDRATED SILICA, BARIUM SULFATE, BHT, SYZYGIUM JAMBOS LEAF EXTRACT, METHICONE, HYDROGEN DIMETHICONE, TETRADECENE, DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE, TIN OXIDE, PHENOXYETHANOL, SODIUM DEHYDROACETATE, TITANIUM DIOXIDE, IRON OXIDES, MICA,
Other information
- protect this product in this container from excessive heat and direct sun.
Questions or comments?
Call toll free 1-800-906-7503
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - I00
SHISEIDO
I00
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - I20
SHISEIDO
I20
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - I40
SHISEIDO
I40
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - I60
SHISEIDO
I60
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - I100
SHISEIDO
I100
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - B00
SHISEIDO
B00
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - B20
SHISEIDO
B20
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - B40
SHISEIDO
B40
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - B60
SHISEIDO
B60
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - B100
SHISEIDO
B100
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - O00
SHISEIDO
O00
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - O20
SHISEIDO
O20
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - O40
SHISEIDO
O40
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - O60
SHISEIDO
O60
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - O80
SHISEIDO
O80
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - BF40
SHISEIDO
BF40
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - WB40
SHISEIDO
WB40
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
PRINCIPAL DISPLAY PANEL - 30mL Bottle Carton - WB60
SHISEIDO
WB60
Radiant Lifting
Foundation
Firming and Anti-wrinkle
BROAD SPECTRUM
SPF 17
sunscreen
30mL NET WT. 1.2 OZ.
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE, DL- | INACTIVE INGREDIENT | WR1WPI7EW8 | 1 | |
| ALUMINUM DISTEARATE | INACTIVE INGREDIENT | 7P1HP1B9UI | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| BARIUM SULFATE | INACTIVE INGREDIENT | 25BB7EKE2E | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 1 | |
| DIETHYLHEXYL SUCCINATE | INACTIVE INGREDIENT | 69W9UMG3P8 | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE | INACTIVE INGREDIENT | 74J1X57U42 | 1 | |
| DIPHENYLSILOXY PHENYL TRIMETHICONE | INACTIVE INGREDIENT | I445L28B12 | 1 | |
| EDETATE TRISODIUM | INACTIVE INGREDIENT | 420IP921MB | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HYDRATED SILICA | INACTIVE INGREDIENT | Y6O7T4G8P9 | 1 | |
| HYDROXYPROLINE | INACTIVE INGREDIENT | RMB44WO89X | 1 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 1 | |
| METHICONE (20 CST) | INACTIVE INGREDIENT | 6777U11MKT | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| NYLON-12 | INACTIVE INGREDIENT | 446U8J075B | 1 | |
| PEG-10 DIMETHICONE (600 CST) | INACTIVE INGREDIENT | 8PR7V1SVM0 | 1 | |
| PEG/PPG-36/41 DIMETHYL ETHER | INACTIVE INGREDIENT | GZ406N3R9F | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| SODIUM DEHYDROACETATE | INACTIVE INGREDIENT | 8W46YN971G | 1 | |
| SODIUM METABISULFITE | INACTIVE INGREDIENT | 4VON5FNS3C | 1 | |
| STANNIC OXIDE | INACTIVE INGREDIENT | KM7N50LOS6 | 1 | |
| SYZYGIUM JAMBOS LEAF | INACTIVE INGREDIENT | 407Z4W5LFF | 1 | |
| TETRADECENE | INACTIVE INGREDIENT | FW23481S7S | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TRIETHOXYCAPRYLYLSILANE | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- SHISEIDO RADIANT LIFTING FOUNDATION I00
- OCTINOXATE and TITANIUM DIOXIDE
- OCTINOXATE
- TITANIUM DIOXIDE
- WATER
- GLYCERIN
- DIMETHICONE
- BUTYLENE GLYCOL
- NYLON-12
- DIETHYLHEXYL SUCCINATE
- DIPHENYLSILOXY PHENYL TRIMETHICONE
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- PEG-10 DIMETHICONE (600 CST)
- CYCLOMETHICONE
- PHENOXYETHANOL
- ALUMINUM HYDROXIDE
- ALUMINUM DISTEARATE
- ALUMINUM OXIDE
- EDETATE TRISODIUM
- SODIUM DEHYDROACETATE
- TRIETHOXYCAPRYLYLSILANE
- .ALPHA.-TOCOPHEROL ACETATE, DL-
- .ALPHA.-TOCOPHEROL
- MICA
- SODIUM METABISULFITE
- HYDRATED SILICA
- LAVENDER OIL
- BARIUM SULFATE
- BUTYLATED HYDROXYTOLUENE
- HYDROXYPROLINE
- PEG/PPG-36/41 DIMETHYL ETHER
- SYZYGIUM JAMBOS LEAF
- METHICONE (20 CST)
- TETRADECENE
- DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE
- STANNIC OXIDE
- SHISEIDO RADIANT LIFTING FOUNDATION I20
- SHISEIDO RADIANT LIFTING FOUNDATION I40
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / EPIDURAL | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / RECTAL | 1 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / INTRAMUSCULAR | 27.5 %w/v | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY / VAGINAL | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING / ORAL | 6 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | OINTMENT / TOPICAL | 5 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / VAGINAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / ORAL | 14 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE / ORAL | 11 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | FILM, SOLUBLE / BUCCAL | 0.07 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL / TOPICAL | 8 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / TOPICAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | FILM, SOLUBLE / ORAL | 0.06 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION, CONCENTRATE / ORAL | 0.1 mg/1ml | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | SYSTEM / TOPICAL | 0.5 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, CHEWABLE / ORAL | 14 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION, SOLUTION / SUBCUTANEOUS | 79 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / SUBMUCOSAL | 5 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / INTRAVENOUS | 27.5 %w/v | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, EXTENDED RELEASE / ORAL | 15 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | SUSPENSION, EXTENDED RELEASE / ORAL | 100 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | GRANULE, FOR SUSPENSION / ORAL | 11 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b3396ded-5fdd-4eb8-8ec3-c38ca620c02a | 1daf11ad-39c0-4538-8a60-7bb0b309afc0 | 2023-12-27 | Warnings | 1daf11ad-39c0-4538-8a60-7bb0b309afc0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.